Ibiglustat (L-Malic acid)
Ibiglustat L-Malic acid is a brain-penetrant, allosteric glucosylceramide synthase inhibitor. Its research applications include investigating substrate reduction therapy (SRT) for lysosomal storage disorders like Gaucher and Fabry disease, as well as exploring its neuroprotective potential in models of Parkinson's disease.
Product Specifications
CAS Number
1629063-78-0
Product Name Alternative
GZ 402671, GZ402671, GZ-402671, GZ402671 (L-Malic acid), glucosylceramide synthase, Glucosylceramide synthase, Ibiglustat L-Malic acid, Ibiglustat, L-Malic acid, SAR402671, SAR-402671, SAR402671 (L-Malic acid), SAR 402671, Venglustat, Venglustat (L-Malic acid)
Field of Research
Metabolism Research
Purity
99.54% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.3 mM) ; DMSO:90 mg/mL (171.9 mM)
Smiles
O[C@@H] (CC (O) =O) C (O) =O.CC (C) (NC (=O) O[C@@H]1CN2CCC1CC2) c1csc (n1) -c1ccc (F) cc1
Molecular Formula
C24H30FN3O7S
Molecular Weight
523.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
